Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

369.15
Delayed Data
As of Dec 08
 +7.14 / +1.97%
Today’s Change
325.35
Today|||52-Week Range
563.79
-32.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
AssetsCash809.1M604.2M646.5M920.4M
 
 
 
 
 
Short Term Investment Cash154.5M-204.9M42.3M273.9M
 
 
 
 
 
Cash & Short Term Investments1.0B849.2M1.0B1.4B
 
 
 
 
 
 
ReceivablesReceivables1.5B1.9B1.8B1.6B
 
 
 
 
 
 
InventoriesInventories238.6M303.3M316.1M345.6M
 
 
 
 
 
 
Current AssetsOther Current Assets163.5M115.7M96.0M103.8M
 
 
 
 
 
Current Assets2.9B3.1B3.2B3.5B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.9B------
 
 
Depreciation-331.1M------
 
 
Other Assets5.8M5.8M6.7M20.7M
 
 
 
 
 
Total Assets5.6B5.9B6.2B6.8B
 
 
 
 
 
 
LiabilitiesAccounts Payable141.0M120.6M101.7M124.5M
 
 
 
 
 
Accrued Expenses369.9M375.9M373.1M295.2M
 
 
 
 
 
Other Current Liabilities537.0M562.4M565.0M541.5M
 
 
 
 
 
Other Liabilities811.2M919.7M951.6M961.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt362.9M362.2M361.5M382.2M
 
 
 
 
 
Deferred Taxes-461.9M-543.7M-626.2M-655.6M
 
 
 
 
 
Other Liabilities115.5M121.0M119.5M135.7M
 
 
 
 
 
Total Liabilities2.0B2.1B2.1B2.3B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity3.7B3.8B4.1B4.5B
 
 
 
 
 
Total Shareholder Equity3.7B3.8B4.1B4.5B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding104.6M105.0M105.3M109.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.